Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0426-2021Class II

EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative...

Epitope Diagnostics, Inc. / initiated 2020-10-01 / Open, Classified / root cause: manufacturing process

Epitope Diagnostics, Inc. began a recall of EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative detection of human anti-COVID-19 IgG antibody in... on . FDA classified it as Class II and gives the reason as "The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0426-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Epitope Diagnostics, Inc.
Product
EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative detection of human anti-COVID-19 IgG antibody in human serum. This kit is to be used as an aid for the detection of novel COVID-19. Patients with suspected clustering cases require diagnosis or differential diagnosis of novel coronavirus infection.
Product code
QKO Reagent, Coronavirus Serological
Reason for recall
The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 10/01/20, the firm, Epitope Diagnostics Inc. (EDI), sent "URGENT: EDI" Novel Coronavirus COVID-19 IgG ELISA Kit Recall" notices were sent to customers. Customers were asked to do the following: Results where the assay controls do not meet the manufacturer's defined specifications should be considered invalid and repeated with another lot. Immediately examine your inventory and quarantine product subject to recall. In addition, if you have further distributed this product, please identify your customers and notify them at once of this product recall. Complete and promptly return the Customer Response Form by Email to: [email protected] or Fax to: 858-693-7877. Your notification to your customers may be enhanced by including a copy of this recall notification letter. For customers located within United States, we will ask that you return this affected product to the recalling firm. For customers located outside United States, please destroy the affected product. For any questions, please refer to EDIs Quality Assurance and Regulatory Affairs Manager, Stefanie Dallezotte, by email: [email protected] or by telephone: +1 858 693 7877.
Quantity in commerce
2886
Distribution
U.S Distribution.: NH, CO, OR, CA, FL, NY, MD, NJ, IL, NC, MI, TX, PA, MA, OH, NM, VA, SC, HI, and TN.
Product codes and lots
Lot Numbers: P826, P815, P796, P776

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0426-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0426-2021Class IIOngoingVoluntary: Firm initiated